Cybin to Buy Clinical Trial From Entheon Biomedical to Advance Development of CYB004
Cybin to Buy Clinical Trial From Entheon Biomedical to Advance Development of CYB004
Cybin將從Entheon Biomedical購買臨牀試驗以推進CyB004的開發
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊